Literature DB >> 11377922

Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior.

L Caberlotto1, Y L Hurd.   

Abstract

It has been hypothesized that the neuropeptide Y (NPY) system is involved in the pathogenesis of mood disorder. In this study, Y(1) and Y(2) receptor mRNA expression levels were analyzed in the dorsolateral prefrontal cortex of subjects affected with major depression, bipolar disorder, or schizophrenia and compared to normal controls. No significant alterations in Y(1) or Y(2) mRNA expression levels were observed between the groups. However, the Y(2) mRNA expression was elevated in layer IV in subjects with suicide as a cause of death. For the Y(1) mRNA expression, there was a negative correlation with increasing subject age in the prefrontal cortex. Analysis of covariance revealed a significant elevation of the Y(1) mRNA expression levels in individuals with a current history of marijuana use but no other drug. In summary, the current results suggest distinct alterations of the prefrontal Y(1) and Y(2) neuronal populations in aging and suicide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377922     DOI: 10.1016/S0893-133X(00)00231-1

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  11 in total

Review 1.  From synapse to nucleus: novel targets for treating depression.

Authors:  Herbert E Covington; Vincent Vialou; Eric J Nestler
Journal:  Neuropharmacology       Date:  2009-12-17       Impact factor: 5.250

Review 2.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

Review 3.  Epigenetics of the depressed brain: role of histone acetylation and methylation.

Authors:  HaoSheng Sun; Pamela J Kennedy; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

4.  Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study.

Authors:  Anuradha Sharma; Xinguo Ren; Hui Zhang; Ghanshyam N Pandey
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-08-17       Impact factor: 5.067

5.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

6.  G protein-linked signaling pathways in bipolar and major depressive disorders.

Authors:  Hiroaki Tomita; Mary E Ziegler; Helen B Kim; Simon J Evans; Prabhakara V Choudary; Jun Z Li; Fan Meng; Manhong Dai; Richard M Myers; Charles R Neal; Terry P Speed; Jack D Barchas; Alan F Schatzberg; Stanley J Watson; Huda Akil; Edward G Jones; William E Bunney; Marquis P Vawter
Journal:  Front Genet       Date:  2013-12-23       Impact factor: 4.599

7.  Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson's Disease with Comorbid Depression versus Patients with Major Depressive Disorder.

Authors:  Per Svenningsson; Sven Pålhagen; Aleksander A Mathé
Journal:  Front Psychiatry       Date:  2017-06-12       Impact factor: 4.157

Review 8.  The role of neuropeptides in suicidal behavior: a systematic review.

Authors:  Gianluca Serafini; Maurizio Pompili; Daniel Lindqvist; Yogesh Dwivedi; Paolo Girardi
Journal:  Biomed Res Int       Date:  2013-08-06       Impact factor: 3.411

9.  Turning the 'Tides on Neuropsychiatric Diseases: The Role of Peptides in the Prefrontal Cortex.

Authors:  Dakota F Brockway; Nicole A Crowley
Journal:  Front Behav Neurosci       Date:  2020-10-20       Impact factor: 3.558

10.  A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder.

Authors:  Aleksander A Mathé; Miranda Michaneck; Elisabeth Berg; Dennis S Charney; James W Murrough
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-29       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.